Charles River Laboratories

Charles River Laboratories

CRL · NYSE
CRL · NYSE
315.43
USD-13.32-4.05%

Data

Ticker

Titolo

Fonte

    #earnings before the open tomorrow https://t.co/lObOE0dOhZ $JD $FVRR $DNUT $YETI $CYBR $VERU $HMC $BLDE $TPR $ENTG $HOOK $AQN $NICE $CRL $TNK $USFD $RVLP $HIMX $BAYRY $ATHM $ALT $DRIO $SOHO $SANW $RWLK $BFLY $HUT $PGTI $KOPN $UTZ $CMMB $VRME $SDIG $PKI $TAST $BWEN $GERN $VNRX… https://t.co/yJX909k2ai

    eWhispers
    @eWhispers

      Upgrades $MU $CRL $VOYA $RITM $CBOE https://t.co/eAzzXmWAk3 https://t.co/7XgMb6gMMZ

      DeItaone
      @DeItaone

        Bigger-than-usual #earnings moves today from $PLTK $CRTO $KPTI $ZG $PRG $ATVI $CERS $BCRX $TCS $SGRY $MDXG $LIVN $FMC $CPRI $MG $SMG $EXEL $CRL https://t.co/1pgojKC5HH https://t.co/qlo927tmnf

        eWhispers
        @eWhispers

          #earnings before the open https://t.co/lObOE0dgsr $CVS $NCLH $BCRX $EXPI $MAR $CWH $DISCA $AUPH $CPRI $FUN $CVE $WING $AMRN $SMG $ATY $AAWW $HUM $SPR $HZNP $SHOO $TUP $CLVS $LL $SUN $IONS $GTHX $SID $BWA $EAT $EVRI $CDW $MCS $EXC $CRL $PBI $RADA $VSH $ATH $HFC $EMR $JLL $ETR https://t.co/DGjRvr2fMH

          eWhispers
          @eWhispers

            Orphazyme stock plunges after receiving CRL from FDA after review of NPC treatment - MarketWatch

            MarketWatch

            FAQ

            Berapa harga saham Charles River Laboratories hari ini?

            Apa simbol saham Charles River Laboratories?

            Apakah harga saham CRL naik?

            Apa rekomendasi analis untuk CRL?

            Apa kapitalisasi pasar CRL?

            Apakah CRL merilis laporan keuangan?

            Kapan tanggal laporan pendapatan CRL berikutnya?

            Berapa pendapatan CRL untuk kuartal terakhir?

            Berapa pendapatan CRL untuk kuartal terakhir?

            Berapa Laba Bersih CRL untuk kuartal terakhir?

            ¿CRL paga dividendos?

            ¿Cuántos empleados tiene CRL?

            ¿Qué es el EBITDA de CRL?

            ¿Cómo comprar acciones de CRL?

            ¿Debería invertir en las acciones de CRL?